Prediction and Evaluation of Anlotinib Treatment Response Using Contrast Enhanced Ultrasound PPGL Patients
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Peking Union Medical College Hospital
Institut Bergonié
Provectus Pharmaceuticals
SpeciCare
Xiangya Hospital of Central South University
Fudan University
Hospices Civils de Lyon
GERCOR - Multidisciplinary Oncology Cooperative Group
Peking University
National Cancer Institute (NCI)
University of Jena